Sirio Pharma Co., Ltd. (SHE:300791)
China
· Delayed Price · Currency is CNY 20.55
-0.47 (-2.24%)
At close: Mar 9, 2026
Sirio Pharma Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 6,288 | 6,167 | 6,293 | 6,637 | 7,513 | 11,035 | Upgrade
|
| Market Cap Growth | 5.82% | -2.01% | -5.18% | -11.66% | -31.92% | 123.46% | Upgrade
|
| Enterprise Value | 7,484 | 7,186 | 7,062 | 6,079 | 7,014 | 10,638 | Upgrade
|
| Last Close Price | 20.55 | 19.82 | 19.44 | 20.39 | 22.75 | 33.20 | Upgrade
|
| PE Ratio | 18.15 | 18.97 | 22.39 | 31.26 | 32.41 | 42.88 | Upgrade
|
| Forward PE | 22.90 | 15.13 | 19.62 | 25.53 | - | - | Upgrade
|
| PS Ratio | 1.41 | 1.46 | 1.76 | 2.65 | 3.17 | 5.34 | Upgrade
|
| PB Ratio | 2.29 | 2.34 | 2.45 | 2.46 | 2.95 | 5.06 | Upgrade
|
| P/TBV Ratio | 3.70 | 3.95 | 4.42 | 2.81 | 3.38 | 5.88 | Upgrade
|
| P/FCF Ratio | 30.48 | 39.83 | - | 43.90 | - | 114.44 | Upgrade
|
| P/OCF Ratio | 9.04 | 10.88 | 16.30 | 14.92 | 22.01 | 34.53 | Upgrade
|
| EV/Sales Ratio | 1.68 | 1.71 | 1.97 | 2.42 | 2.96 | 5.15 | Upgrade
|
| EV/EBITDA Ratio | 11.98 | 11.74 | 11.83 | 16.57 | 18.49 | 30.09 | Upgrade
|
| EV/EBIT Ratio | 17.20 | 16.74 | 18.77 | 25.06 | 24.95 | 38.85 | Upgrade
|
| EV/FCF Ratio | 36.28 | 46.41 | - | 40.21 | - | 110.32 | Upgrade
|
| Debt / Equity Ratio | 0.62 | 0.61 | 0.53 | 0.35 | 0.34 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 2.73 | 2.48 | 2.16 | 2.50 | 2.27 | 0.10 | Upgrade
|
| Debt / FCF Ratio | 8.27 | 10.38 | - | 6.20 | - | 0.36 | Upgrade
|
| Net Debt / Equity Ratio | 0.40 | 0.31 | 0.24 | -0.28 | -0.15 | -0.30 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.87 | 1.36 | 1.03 | -2.05 | -0.98 | -1.85 | Upgrade
|
| Net Debt / FCF Ratio | 5.34 | 5.36 | -9.36 | -4.98 | 2.03 | -6.80 | Upgrade
|
| Asset Turnover | 0.80 | 0.79 | 0.76 | 0.63 | 0.73 | 0.83 | Upgrade
|
| Inventory Turnover | 5.56 | 6.01 | 7.00 | 7.36 | 6.34 | 5.97 | Upgrade
|
| Quick Ratio | 1.35 | 1.82 | 1.88 | 4.62 | 4.88 | 2.59 | Upgrade
|
| Current Ratio | 1.89 | 2.45 | 2.57 | 5.18 | 5.76 | 3.42 | Upgrade
|
| Return on Equity (ROE) | 10.94% | 10.83% | 9.12% | 8.09% | 9.81% | 12.47% | Upgrade
|
| Return on Assets (ROA) | 4.87% | 5.02% | 5.01% | 3.79% | 5.43% | 6.83% | Upgrade
|
| Return on Invested Capital (ROIC) | 10.04% | 11.49% | 12.90% | 9.94% | 12.54% | 14.22% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.10% | 9.20% | 8.50% | 6.50% | 8.10% | 12.10% | Upgrade
|
| Earnings Yield | 5.50% | 5.27% | 4.47% | 3.20% | 3.09% | 2.33% | Upgrade
|
| FCF Yield | 3.28% | 2.51% | -1.04% | 2.28% | -2.44% | 0.87% | Upgrade
|
| Dividend Yield | 2.38% | 2.52% | 3.35% | 1.01% | 1.04% | 0.71% | Upgrade
|
| Payout Ratio | 49.89% | 67.56% | 29.83% | 35.84% | 31.29% | 10.05% | Upgrade
|
| Buyback Yield / Dilution | -0.24% | 0.36% | 0.82% | 4.47% | -5.00% | -23.77% | Upgrade
|
| Total Shareholder Return | 2.14% | 2.88% | 4.17% | 5.49% | -3.96% | -23.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.